The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $62.21

Today's change-0.32 -0.51%
Updated January 23 10:00 AM EST. Delayed by at least 15 minutes.
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $62.21

Today's change-0.32 -0.51%
Updated January 23 10:00 AM EST. Delayed by at least 15 minutes.

Merck & Co Inc down (U.S.)$0.32

Merck & Co Inc is lower today, dropping (U.S.)$0.32 or 0.51% to (U.S.)$62.21. Over the last five days, shares are unchanged, but currently 4.96% below the 52-week high. This security has outperformed the S&P 500 by 2.17% during the last year.

Key company metrics

  • Open(U.S.) $61.81
  • Previous close(U.S.) $62.53
  • High(U.S.) $62.30
  • Low(U.S.) $61.63
  • Bid / Ask(U.S.) $62.20 / (U.S.) $62.21
  • YTD % change+5.67%
  • Volume1,374,613
  • Average volume (10-day)15,820,441
  • Average volume (1-month)11,914,638
  • Average volume (3-month)11,150,018
  • 52-week range(U.S.) $47.97 to (U.S.) $65.46
  • Beta0.78
  • Trailing P/E31.65×
  • P/E 1 year forward16.51×
  • Forward PEG2.70×
  • Indicated annual dividend(U.S.) $1.88
  • Dividend yield3.02%
  • Trailing EPS(U.S.) $1.97
Updated January 23 10:00 AM EST. Delayed by at least 15 minutes.
S&P TSX0.27%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue10,5369,8449,31210,215
Total other revenue--------
Total revenue10,5369,8449,31210,215
Gross profit7,1636,3325,7876,446
Total cost of revenue3,3733,5123,5253,769
Total operating expense7,6278,3217,6408,496
Selling / general / administrative2,3562,3532,3132,560
Research & development1,6502,0871,6041,780
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)248369198387
Other operating expenses, total--------
Operating income2,9091,5231,6721,719
Interest income (expense), net non-operating-170-171-172-169
Gain (loss) on sale of assets--------
Other--------
Income before tax2,8871,5041,624816
Income after tax2,1881,2091,130982
Income tax, total699295494-166
Net income2,1841,2051,125977
Total adjustments to net income--------
Net income before extra. items2,1841,2051,125977
Minority interest-4-4-5-5
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,1841,2051,125977
Inc. avail. to common incl. extra. items2,1841,2051,125977
Diluted net income2,1841,2051,125977
Dilution adjustment--------
Diluted weighted average shares2,7862,7892,7952,814
Diluted EPS excluding extraordinary itemsvalue per share0.780.430.400.35
Dividends per sharevalue per share0.460.460.460.46
Diluted normalized EPSvalue per share0.850.540.450.44